scholarly article | Q13442814 |
P2093 | author name string | Pereira JM | |
Antunes F | |||
Gomes P | |||
Ferreira MO | |||
Lourenço MH | |||
Taveira NC | |||
P2860 | cites work | HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals | Q43984259 |
A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa | Q44176173 | ||
Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. | Q44192276 | ||
Detection of circulating human immunodeficiency virus type 2 in plasma by reverse transcription polymerase chain reaction | Q45767786 | ||
Lessons from the second AIDS virus, HIV-2. | Q45768295 | ||
Cellular and plasma viral load in patients infected with HIV-2. | Q54480160 | ||
Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection | Q70573580 | ||
Reduced rate of disease development after HIV-2 infection as compared to HIV-1 | Q28237927 | ||
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy | Q28253761 | ||
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy | Q29615993 | ||
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia | Q29615995 | ||
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma | Q29619980 | ||
Slower heterosexual spread of HIV-2 than HIV-1. | Q30419674 | ||
Virological and molecular demonstration of human immunodeficiency virus type 2 vertical transmission | Q33783504 | ||
Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection | Q35369891 | ||
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology | Q36637244 | ||
Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. | Q36824026 | ||
HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau | Q39309472 | ||
A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4. | Q39578487 | ||
Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons. | Q39877474 | ||
Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. | Q40061126 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 453-456 | |
P577 | publication date | 1999-02-01 | |
P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
P1476 | title | Quantitation of human immunodeficiency virus type 2 DNA in peripheral blood mononuclear cells by using a quantitative-competitive PCR assay | |
P478 | volume | 37 |
Q34742090 | Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients |
Q35185919 | Increased frequency of circulating CCR5+ CD4+ T cells in human immunodeficiency virus type 2 infection |
Q92075372 | Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection |
Q33793928 | Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo |
Q30912292 | Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease |
Q34199460 | Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections |
Q33974193 | Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR |
Q43143940 | The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients |